"MMJ Argues Federal Government Cannot Reward State Marijuana Operators While Federally Compliant Pharmaceutical Developers Remain Trapped in Regulatory Limbo" stated Duane Boise CEO MMJ International ...

"As DEA rescheduling cases merge and federal hemp litigation moves to the D.C. Circuit, MMJ argues that companies following FDA rules should not be disadvantaged while non-FDA-approved cannabinoid pro ...

"The MMJ International Holdings case is not just about marijuana. It is about a principle that affects every American who ...

Federally Compliant Pharmaceutical Developer Raises Constitutional, Statutory, Treaty, and Competitive Fairness Objections - ...

MMJ companies are building a center of marijuana excellence in Rhode Island and has filed for FDA sanctioned clinical trials in multiple sclerosis and Huntington's disease. MMJ was awarded the much ...

"After Eight Years, Millions invested, FDA INDs, Orphan Drug Designation, DEA Inspections, and a Completed Federal Investigation, MMJ Demands the Government Explain Why Companies That Followed Federal ...

Recent industry coverage has repeatedly attempted to place participants in the litigation into simplistic categories of either "pro-marijuana" or "anti-marijuana." MMJ rejects that characterization ...